Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.32 |
| ▸ | GABRD | O14764 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.32 |
| ▸ | GABRE | P78334 | 1/20 | 0.32 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.32 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.32 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6344526 | 0.72 | CYP2C19 (0.35) | ALDH1A1AR | |
| SCHEMBL13176256 | 0.70 | — | — | |
| SCHEMBL13697409 | 0.70 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CRBN | |
| SCHEMBL9881076 | 0.70 | SMN1; SMN2 (0.37) | SMN1; SMN2CRBNGABRPGABRDGABRA1 | |
| SCHEMBL13697404 | 0.70 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CRBN | |
| SCHEMBL10431444 | 0.70 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CRBN | |
| SCHEMBL3412400 | 0.67 | — | — | |
| SCHEMBL11443083 | 0.67 | GABRP (0.38) | TDP1SMN1; SMN2ALDH1A1GABRPGABRD | |
| SCHEMBL7113337 | 0.67 | LMNA (0.45) | TDP1SMN1; SMN2ALDH1A1GABRPGABRD | |
| SCHEMBL45956 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240115771-A1 | 3D-PRINTED SCAFFOLDS OF PEPTIDE CONJUGATE POLYMER | LEHIGH UNIVERSITY | 2024-04-11 | — | — | US | claimed |
| WO-2022207920-A1 | MULTIBRANCHED POLYMERS, COMPOSITIONS COMPRISING SAME, METHODS FOR PREPARING SAME, AND USE THEREOF IN ELECTROCHEMISTRY | SCE FRANCE (FR) | 2022-10-06 | — | — | WO | claimed |
| EP-2488567-B1 | PROCESS FOR MAKING POLYESTER OR COPOLYESTER FROM LACTONES | EVONIK DEGUSSA GMBH (DE) | 2015-05-06 | — | — | EP | claimed |
| US-20120202966-A1 | METHOD FOR PRODUCING POLYESTERS AND CO-POLYESTERS FROM LACTONES | EVONIK DEGUSSA GMBH (DE) | 2012-08-09 | — | — | US | claimed |
| US-20100131064-A1 | BIORESORBABLE POLYMER RECONSTITUTED BONE AND METHODS OF FORMATION THEREOF | UNIVERSITY OF NEBRASKA (US) | 2010-05-27 | — | — | US | claimed |
| US-20090092801-A1 | NONAQUEOUS INKJET INK, INK COMPOSITION FOR INKJET RECORDING, AND SUBSTRATE FOR COLOR FILTER | TOYO INK MANUFACTURING CO., LTD. (JP) | 2009-04-09 | — | — | US | claimed |
| EP-1778760-A4 | BIORESORBABLE COMPOSITES AND METHOD OF FORMATION THEREOF | UNIV NEBRASKA (US) | 2009-01-21 | — | — | EP | claimed |
| EP-2007317-A2 | BIORESORBABLE POLYMER RECONSTITUTED BONE AND METHODS OF FORMATION THEREOF | University Of Nebraska (US) | 2008-12-31 | — | — | EP | claimed |
| US-20080200638-A1 | Bioresorbable Composites and Method of Formation Thereof | NATIONAL SCIENCE FOUNDATION | 2008-08-21 | — | — | US | claimed |
| WO-2008095083-A1 | BIORESORBABLE POLYMER/CALCIUM SULFATE COMPOSITES AND METHOD OF FORMATION THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2008-08-07 | — | — | WO | claimed |
| WO-2007140325-A2 | BIORESORBABLE POLYMER RECONSTITUTED CERAMIC MATRICES AND METHODS OF FORMATION THEREOF | UNIVERSITY OF NEBRASKA OFFICE OF TECHNOLOGY DEVELOPMENT (US) | 2007-12-06 | — | — | WO | claimed |
| WO-2007117499-A2 | BIORESORBABLE POLYMER RECONSTITUTED BONE AND METHODS OF FORMATION THEREOF | UNIVERSITY OF NEBRASKA (US) | 2007-10-18 | — | — | WO | claimed |
| EP-1778760-A1 | BIORESORBABLE COMPOSITES AND METHOD OF FORMATION THEREOF | University of Nebraska (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006015316-A1 | BIORESORBABLE COMPOSITES AND METHOD OF FORMATION THEREOF | UNIVERSITY OF NEBRASKA (US) | 2006-02-09 | — | — | WO | claimed |
| US-20040068059-A1 | Aliphatic polyester copolymer and process for producing the same, biodegradable resin molding based on aliphatic polyester, and lactone-containing resin | DAICEL CHEMICAL INDUSTRIES LTD. (JP) | 2004-04-08 | — | — | US | claimed |
| EP-1354908-A1 | ALIPHATIC POLYESTER COPOLYMER AND PROCESS FOR PRODUCING THE SAME, BIODEGRADABLE RESIN MOLDING BASED ON ALIPHATIC POLYESTER, AND LACTONE-CONTAINING RESIN | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2003-10-22 | — | — | EP | claimed |
| US-12600857-B2 | Polyether block amide-poly(meth)acrylate foams | EVONIK OPERATIONS GMBH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-12565559-B2 | Water-dispersible modified polyisocyanates | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-03 | — | — | US | disclosed |
| EP-0459913-A2 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-04 | — | — | EP | disclosed |
| EP-0409735-A1 | A polycaprolactone polyol and hydrolysis resistant polyurethane resins prepared therefrom | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600857-B2 | Polyether block amide-poly(meth)acrylate foams | MMAB, EIF2B1, EIF2B3 | GAA 4820/4885TDP1 2320/4885SMN1; SMN2 2580/4885 |
| US-12565559-B2 | Water-dispersible modified polyisocyanates | INTS9, PRMT9, IPO9 | GAA 4557/4885TDP1 2119/4885SMN1; SMN2 710/4885 |
| US-20100131064-A1 | BIORESORBABLE POLYMER RECONSTITUTED BONE AND METHODS OF FORMATION THEREOF | BMP2, PTH1R, BMP4 | GAA 1810/4885TDP1 4670/4885SMN1; SMN2 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.